|
Match
|
Document |
Document Title |
|
|
US20090311318 |
SUBSTITUTED (S)-BENZOXAZINONES
The present invention provides enantiomerically pure substituted (S)-benzoxazinone compounds and an extended release formulation of the compounds. The compounds exhibit potent renin inhibition...
|
|
|
US20090304789 |
NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS
The present invention is drawn to novel topiramate compositions as well as methods for treating obesity and related conditions, including conditions associated with and/or caused by obesity per se....
|
|
|
US20090238868 |
ABUSE-RESISTANT ORAL DOSAGE FORMS AND METHOD OF USE THEREOF
An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but...
|
|
|
US20090232888 |
SUSTAINED DELIVERY OF ANTIBIOTICS
The present invention is directed to compositions for the sustained delivery of an antibiotic, for example vancomycin, to achieve desirable release profiles. This application is also directed to...
|
|
|
US20090232887 |
PHARMACEUTICAL COMPOSITION HAVING REDUCED ABUSE POTENTIAL
A pharmaceutical paste composition comprising an active ingredient such as an addictive substance, a controlled release agent, and a pharmaceutically suitable aqueous or non-aqueous carrier. The...
|
|
|
US20090214642 |
COATED FORMULATIONS FOR TOLTERODINE
A sustained release pharmaceutical composition comprising coating comprising at least one water-insoluble permeable polymer and at least one water soluble polymer and homogenous cores containing...
|
|
|
US20090202629 |
Controlled release hydrocodone formulations
A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof,...
|
|
|
US20090196921 |
Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition
Disclosed herein are compositions for treating a respiratory condition, preferably by enhancing immune response in a mammal, the compositions including a therapeutic amount of a probiotic strain of...
|
|
|
US20090169616 |
FORMULATION AND METHOD FOR THE RELEASE OF PAROXETINE IN THE LARGE INTESTINE
The present invention provides a delayed and/or controlled release formulation of paroxetine or a pharmaceutically acceptable salt thereof that is formulated to release a substantial portion of the...
|
|
|
US20090155357 |
Alcohol Resistant Pharmaceutical Formulations
The present invention provides alcohol resistant oral dosage pharmaceutical forms and methods of using such oral dosage forms to avoid dose dumping if the dosage form is taken together with alcohol.
|
|
|
US20090155358 |
PHARMACEUTICAL COMPOSITIONS OF SHORT-ACTING HYPNOTIC AGENTS IN MODIFIED-RELEASE FORMS AND THE PROCEDURES TO PREPARE THE MENTIONED FORMULATION
This application refers to a modified-release pharmaceutical composition containing, as the active agent, a short-acting hypnotic agent or a pharmaceutically acceptable salt thereof, comprising two...
|
|
|
US20090148518 |
Pharmaceutical Formulations
The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or multi-component pharmaceutical dosage...
|
|
|
US20090130204 |
Dosage Form Comprising Therapeutic Formulation
A dosage form is disclosed comprising a semipermeable walled container that houses a capsule, which capsule comprises a drug formulation, a piston, and an osmotic composition. The dosage form...
|
|
|
US20090123535 |
Oral Controlled Release Formulation for Sedatives and Hypnotic Agents
The present invention relates to a novel controlled release dosage form that releases therapeutic amounts of a sedative or hypnotic agent rapidly after administration and maintains therapeutic...
|
|
|
US20090118579 |
MEDICAL CAPSULE
A medical capsule having a capsule configuration of size permitting introduction in a body, adapted to be at least partially dissolved over time by remaining in the intestines for a predetermined...
|
|
|
US20090098201 |
Composition and Method for Treatment and Prevention of Atherosclerosis
This invention relates to an oral composition for treatment or prevention of atherosclerosis comprising a low-dose aspirin and a low-dose of statin wherein the aspirin and statin are in a...
|
|
|
US20090087484 |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
A formulation and dosage form for enhancing the bioavailability of orally administered hydrophilic macromolecules includes a permeation enhancer, a hydrophilic macromolecule, and a carrier such as...
|
|
|
US20090074858 |
SUSTAINED-RELEASE FORMULATION
A sustained-release formulation is provided comprising a solid dispersion composition comprising a tricyclic compound or a pharmaceutically acceptable salt thereof in a mixture comprising a...
|
|
|
US20090060994 |
Controlled release azithromycin solid dosages forms
A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
|
|
|
US20090061048 |
DELIVERY AND CONTROLLED RELEASE OF ENCAPSULATED LIPOPHILIC NUTRIENTS
A complex coacervate delivery system is provided which encapsulates lipophilic nutrients such as, for example, fish oils high in omega-3 fatty acids. The complex coacervate delivery system protects...
|
|
|
US20090041840 |
Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
A novel sleep regulating pharmaceutical formulation is introduced, typically implementing two principal drugs having actions which are reversive to one another, yet incorporated into a unitary...
|
|
|
US20090035370 |
DOSAGE FORM AND METHOD OF USE
A method for treating a medical condition for which quetiapine is indicated in a subject comprises comprising orally administering to the subject quetiapine or a pharmaceutically acceptable salt...
|
|
|
US20090022790 |
TAMPER RESISTANT CO-EXTRUDED DOSAGE FORM CONTAINING AN ACTIVE AGENT AND AN ADVERSE AGENT AND PROCESS OF MAKING SAME
The present invention relates to co-extruded pharmaceutical compositions and dosage forms including an active agent, such as an opioid agonist, and an adverse agent, such as an opioid antagonist....
|
|
|
US20090022789 |
ENHANCED FORMULATIONS OF LAMOTRIGINE
A once-a-day, extended-release formulation of lamotrigine, exhibiting a significantly similar release rate throughout the GI tract irrespective of the pH of the environment, is provided. The...
|
|
|
US20090011011 |
STABLE DOSAGE FORMULATIONS OF IMIDAZOLYLALKYL-PYRIDINES
Stable formulations of imidazolylalkyl-pyridines, including controlled-release formulations.
|
|
|
US20080311187 |
CRUSH RESISTAN DELAYED-RELEASE DOSAGE FORM
The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or...
|
|
|
US20080311191 |
Multi-Layer Tablets and Bioadhesive Dosage Forms
Bioadhesives coatings increase the gastrointestinal retention time of orally-ingested medicaments. Certain bioadhesive coatings producing a fracture strength of at least 100 N/m 2 , as measured on...
|
|
|
US20080299189 |
CONTROLLED RELEASE DOPAMINE AGONIST COMPOSITIONS
The present invention relates to a multiphase release oral pharmaceutical formulation having a dopamine agonist as an active ingredient. The multiphase composition comprises at least two different...
|
|
|
US20080299188 |
CONTROLLED RELEASE DOSAGE FORMS COMBINING IMMEDIATE RELEASE AND SUSTAINTED RELEASE OF LOW-SOLUBILITY DRUG
A controlled release dosage form comprises an immediate release portion and an enteric coated sustained release core.
|
|
|
US20080260817 |
Compositions for the Treatment of Inflammation and Pain Using a Combination of a Cox-2 Selective Inhibitor and a Ltb4 Receptor Antagonist
The present invention provides a therapeutic composition comprising a COX-2 selective inhibitor or a prodrug thereof and an LTB 4 receptor antagonist. A method is provided for the use of such...
|
|
|
US20080206322 |
Pharmaceutical Multiparticulate Composit Ion Comprising Mycophenolic Acid or Myco Phenolate Sodium and Combination Compositions with Rapamycin
The present invention relates to a novel composition, e.g. of mycophenolic acid, a salt or a prodrug thereof, in a modified release form.
|
|
|
US20080187580 |
Therapeutic nucleosides
The use of a 1,3-oxathiolane nucleoside analogue and pharmaceutically acceptable derivatives thereof for the treatment of hepatitis B virus infections is disclosed. Pharmaceutical formulations are...
|
|
|
US20080181941 |
ORALLY ADMINISTRABLE OPIOID FORMULATIONS HAVING EXTENDED DURATION OF EFFECT
Sustained release oral solid dosage forms of opioid analgesics are provided as multiparticulate systems which are bioavailable and which provide effective blood levels of the opioid analgesic for...
|
|
|
US20080181932 |
COMPOSITIONS FOR ORAL DELIVERY OF PHARMACEUTICALS
The invention provides methods and compositions for the oral delivery of pharmaceutically active agents. In particular, the compositions generally comprise a plurality of pharmaceutically active...
|
|
|
US20080181944 |
Dosage Form Comprising Therapeutic Formulation
A dosage form is disclosed comprising a semipermeable walled container that houses a capsule, which capsule comprises a drug formulation, a piston, and an osmotic composition. The dosage form...
|
|
|
US20080152709 |
CLONIDINE COMPOSITION AND METHOD OF USE
A pharmaceutical composition comprises clonidine or a pharmaceutically acceptable salt or prodrug thereof. The composition, when administered to a patient in an amount delivering a clonidine dose...
|
|
|
US20080138406 |
COMPOSITION FOR TREATMENT OF PAIN IN BONES AND JOINTS
The present invention is a composition delivering effective amounts of Glucosamine, Devils Claw, and SAM in a single dosage unit.
|
|
|
US20080138407 |
CAPSULE MEDICATION ADMINISTRATION SYSTEM AND MEDICATION ADMINISTRATION METHOD
A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug...
|
|
|
US20080131502 |
CAPSULE MEDICATION ADMINISTRATION SYSTEM AND MEDICATION ADMINISTRATION METHOD
A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug...
|
|
|
US20080107727 |
Multiple Unit Oral Sustained Release Preparation and Production Method Thereof
A multiple-unit oral sustained release preparation is provided which allows controlled release of imidafenacin [4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide]. The preparation serves to ensure a...
|
|
|
US20080102115 |
Modified coagulation factor IX polypeptides and use thereof for treatment
Provided are modified factor IX (FIX) polypeptides and methods of generating modified FIX polypeptides. Also provided are pharmaceutical compositions, including compositions formulation for oral...
|
|
|
US20080095839 |
Controlled-Release Pharmaceutical Composition and Method for Producing the Same
It is an object of the present invention, in the case of a controlled-release pharmaceutical composition, particularly a pulsed-release pharmaceutical composition, containing an acid-unstable...
|
|
|
US20080085304 |
Robust sustained release formulations
Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided....
|
|
|
US20080085305 |
Robust sustained release formulations of oxymorphone
Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided....
|
|
|
US20080081067 |
SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS OF VENLAFAXINE AND PROCESS FOR PREPARATION THEREOF
The invention relates to sustained release pharmaceutical compositions of venlafaxine, process for preparing such compositions and method of using such compositions. Preferably, it relates to a...
|
|
|
US20080069872 |
Multi-Layered Controlled-Release Methylphenidate Pellet
The present invention relates to a type of controlled-release multilayered methylphenidate pellet that does not need to be combined with another type of pellet. It allows the maintenance of...
|
|
|
US20080057118 |
DIVALPROEX PHARMACEUTICAL COMPOSITIONS
Pharmaceutical compositions comprising a valproic acid drug compound, providing modified release of the drug.
|
|
|
US20080050427 |
Analgesic combination of tramadol and meloxicam
Disclosed is a pharmaceutical composition, comprising a combination of a dose of meloxicam or a pharmaceutically acceptable salt thereof and a dose of oxycodone or a pharmaceutically acceptable...
|
|
|
US20080044442 |
Container for an Inhalation Anesthetic
The specification and drawings describe and show one preferred embodiment or a small number of preferred embodiments of the present invention in the form of a container constructed from or lined...
|
|
|
US20080031940 |
Quercetin-containing composition, methods of making, and methods of using
|